Home › Research › Topics › tau-pet
tau-pet
8 studies tagged tau-pet, dated 2021-01-04 to 2025-05-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers 2025-05-01
- The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study 2024-10-19
- A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings 2024-03-14
Studies
8 studies carry this tag.
Date range
2021 to 2025
Top journals
- Alzheimer's research & therapy 3
- Alzheimer's & dementia : the journal of the Alzheimer's Association 2
- Brain : a journal of neurology 1
- European journal of nuclear medicine and molecular imaging 1
- Nature communications 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
64/100
The CI group had more longitudinal synapse loss and tau burden increases than HCs.
-
69/100
In TAP-TAU, we will investigate the added clinical value of tau-PET in a real-world clinical setting, including memory clinic patients with diagnostic uncertainty after routine work-up.
-
Blood-based biomarkers for screening may guide tau positrion emissition tomography (PET) scan referrals to optimize prognostic evaluation in Alzheimer's disease.
-
Women show stronger associations between tau PET and cognitive outcomes in preclinical AD.
-
The A+P+T- group showed a slower rate of increase in tau-PET compared to the A+P+T+ group, primarily in neocortical regions.
-
52/100
Neither HOMA-IR nor diabetic status was significantly associated with tau PET SUVR.
-
The BHA measures are significantly associated with both Aβ and regional tau in vivo imaging markers and could be used for the identification of patients with suspected AD pathology in clinical practice.
-
The choice of tau biomarker may differ by disease stage and research goals that seek to maximize sensitivity or specificity.